The GLP-1 boom is making people desperate to get the pricey weight-loss drugs. They won't get the real medication in "GLP-1 patches," doctors warn.

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

Weight-loss medications like Ozempic and Wegovy became household names a few years ago when celebrities began using them. Now ...

Are compounded GLP-1s for weight loss safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat ...

A class action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lily’s blockbuster GLP-1 drug to treat obesity.

We're learning more and more about the far-reaching benefits of the new weight loss GLP-1 drugs, such as Ozempic, Wegovy, Mounjaro and Zepbound. For example, a study in JAMA Oncology shows that folks ...

Oral GLP-1s are coming. Will they expand treatment options or simply complement injectables? Obesity specialists share their ...

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) beneficiaries as of Aug. 31, though the other TRICARE plans continue to offer ...